0001179110-22-000961.txt : 20220209 0001179110-22-000961.hdr.sgml : 20220209 20220209163353 ACCESSION NUMBER: 0001179110-22-000961 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220207 FILED AS OF DATE: 20220209 DATE AS OF CHANGE: 20220209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Guerin Mark Patrick CENTRAL INDEX KEY: 0001607714 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36020 FILM NUMBER: 22607712 MAIL ADDRESS: STREET 1: 375 PHEASANT RUN CITY: NEWTOWN STATE: PA ZIP: 18940 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Onconova Therapeutics, Inc. CENTRAL INDEX KEY: 0001130598 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 375 PHEASANT RUN CITY: NEWTOWN STATE: PA ZIP: 18940 BUSINESS PHONE: 267-759-3681 MAIL ADDRESS: STREET 1: 375 PHEASANT RUN CITY: NEWTOWN STATE: PA ZIP: 18940 FORMER COMPANY: FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS, INC. DATE OF NAME CHANGE: 20090526 FORMER COMPANY: FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS INC DATE OF NAME CHANGE: 20001226 4 1 edgar.xml FORM 4 - X0306 4 2022-02-07 0 0001130598 Onconova Therapeutics, Inc. ONTX 0001607714 Guerin Mark Patrick C/O ONCONOVA THERAPEUTICS, INC. 12 PENNS TRAIL NEWTOWN PA 18940 0 1 0 0 Chief Financial Officer Stock Option (right to purchase) 1.82 2022-02-07 4 A 0 62100 0 A 2032-02-07 Common stock 62100 62100 D Restricted Stock Units 2022-02-07 4 A 0 20700 0 A Common stock 20700 20700 D These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. Each restricted stock unit is convertible into one share of common stock. /s/ Mark Guerin 2022-02-09